Abstract
Calcification is the most frequent cause of the failure of bioprosthetic heart valves fabricated from glutaraldehyde pretreated porcine aortic valves or bovine pericardium. Formulation and evaluation of controlled-release drug delivery system to inhibit bioprosthetic heart valve calcification is reviewed.
| Original language | English |
|---|---|
| Pages (from-to) | 266-289 |
| Number of pages | 24 |
| Journal | Journal of Biomaterials Applications |
| Volume | 2 |
| Issue number | 2 |
| DOIs | |
| State | Published - Apr 1987 |
Fingerprint
Dive into the research topics of 'Controlled Release of Diphosphonates from Synthetic Polymers to Inhibit Calcification'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver